Biotechnology companies play a vital role in advancing medical innovations and therapies, including breakthroughs and the development of novel therapies for various diseases.
The PRISM Emerging Biotech Index tracks small and micro-cap stocks that are contributing to healthcare innovation and economic growth.
PRISM Emerging Biotech IndexInception Date of 1/2/2024 at $100.00 | % Change (Daily) | Current Index Value | % Change (Inception) | |||||
---|---|---|---|---|---|---|---|---|
-1.4% | $132.60 | 32.6% | ||||||
Index Components | Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volume (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
Equillium, Inc. | EQ | $0.83 | -12.11% | 1,328 | 789 | $29 | $0.73 | 13.0% |
NeuroBo Pharmaceuticals, Inc. | NRBO | $2.36 | 0% | 0 | 0 | $20 | $4.11 | -42.6% |
Immuron Limited | IMRN | $1.96 | -4.85% | 1 | 12 | $11 | $1.90 | 3.2% |
Creative Medical Technology Holdings, Inc. | CELZ | $4.20 | 18.31% | 134 | 43 | $7 | $4.60 | -8.7% |
Kamada Ltd. | KMDA | $7.95 | 15.05% | 770 | 79 | $457 | $6.16 | 29.1% |
Achilles Therapeutics plc | ACHL | $1.38 | -0.72% | 1,412 | 468 | $57 | $0.87 | 58.3% |
Adverum Biotechnologies, Inc. | ADVM | $4.31 | -0.23% | 128 | 219 | $90 | $0.83 | 420.5% |
iBio, Inc. | IBIO | $3.74 | 4.1% | 313 | 173 | $37 | $1.38 | 170.8% |
AIM ImmunoTech Inc. | AIM | $0.15 | -5.6% | 3,688 | 740 | $10 | $0.48 | -69.5% |
Palisade Bio, Inc. | PALI | $1.25 | -3.85% | 116 | 1,577 | $3 | $0.58 | 115.9% |
BioLineRx Ltd. | BLRX | $3.39 | -2.87% | 128 | 7,854 | $13 | $1.53 | 121.6% |
Immatics N.V. | IMTX | $5.40 | -4.43% | 440 | 932 | $645 | $10.72 | -49.6% |
Vaxart, Inc. | VXRT | $0.71 | -3.9% | 1,801 | 1,804 | $161 | $0.61 | 16.6% |
Capricor Therapeutics, Inc. | CAPR | $14.24 | -0.63% | 1,000 | 1,185 | $647 | $5.12 | 178.1% |
Lisata Therapeutics, Inc. | LSTA | $2.60 | -1.14% | 3 | 43 | $22 | $2.78 | -6.5% |
Quince Therapeutics, Inc. | QNCX | $1.48 | -6.33% | 348 | 221 | $65 | $1.04 | 42.3% |
NeuroSense Therapeutics Ltd. | NRSN | $1.15 | -3.28% | 82 | 286 | $27 | $0.80 | 43.9% |
Addex Therapeutics Ltd | ADXN | $7.74 | -0.39% | 4 | 38 | $12 | $6.30 | 22.9% |
ZyVersa Therapeutics, Inc. | ZVSA | $1.20 | -2.83% | 46 | 852 | $3 | $0.88 | 36.4% |
Metagenomi, Inc. Common Stock | MGX | $2.48 | -6.06% | 637 | 2,457 | $93 | $10.31 | -75.9% |
180 Life Sciences Corp. | ATNF | $1.40 | 1.45% | 45 | 450 | $4 | $3.91 | -64.2% |
OS Therapies Incorporated | OSTX | $1.95 | 0.52% | 215 | 490 | $41 | $4.41 | -55.8% |
Klotho Neuroscience Inc. | KLTO | $0.35 | -3.32% | 62 | 846 | $9 | $1.73 | -79.8% |
Annexon, Inc. | ANNX | $3.44 | -3.64% | 863 | 1,437 | $367 | $4.84 | -28.9% |
Poseida Therapeutics, Inc. | PSTX | $9.50 | 0% | 21,344 | 1,798 | $926 | $3.38 | 181.1% |
Rezolute, Inc. | RZLT | $4.91 | -3.73% | 366 | 498 | $285 | $1.02 | 383.7% |
Foghorn Therapeutics Inc. | FHTX | $4.75 | 15.29% | 243 | 147 | $264 | $8.45 | -43.8% |
Innate Pharma S.A. | IPHA | $1.90 | -4.52% | 30 | 518 | $159 | $5.72 | -66.8% |
Chemomab Therapeutics Ltd. | CMMB | $1.94 | -7.18% | 71 | 109 | $37 | $0.54 | 260.7% |
Plus Therapeutics, Inc. | PSTV | $1.24 | -3.41% | 16 | 55 | $7 | $1.85 | -33.2% |
Ardelyx, Inc. | ARDX | $5.57 | -1.76% | 3,996 | 4,839 | $1,319 | $6.05 | -7.9% |
Eupraxia Pharmaceuticals Inc. | EPRX | $3.21 | 1.91% | 8 | 13 | $114 | $4.16 | -22.9% |
Taysha Gene Therapies, Inc. | TSHA | $1.75 | 5.42% | 3,181 | 4,131 | $359 | $1.71 | 2.3% |
Oragenics, Inc. | OGEN | $0.25 | -14.04% | 3,113 | 5,346 | $3 | $6.78 | -96.4% |
Entrada Therapeutics, Inc. | TRDA | $12.96 | -3.86% | 94 | 123 | $485 | $15.17 | -14.6% |
Akebia Therapeutics, Inc. | AKBA | $2.16 | -0.93% | 1,422 | 2,221 | $471 | $1.27 | 70.1% |
Enliven Therapeutics, Inc. | ELVN | $22.00 | -2.09% | 188 | 232 | $1,075 | $14.90 | 47.7% |
TG Therapeutics, Inc. | TGTX | $33.00 | -1.49% | 1,342 | 2,707 | $5,137 | $17.04 | 93.7% |
Myriad Genetics, Inc. | MYGN | $12.41 | -2.51% | 834 | 1,042 | $1,130 | $19.00 | -34.7% |
Coya Therapeutics, Inc. | COYA | $6.88 | -1.72% | 63 | 68 | $115 | $6.96 | -1.2% |
Ocular Therapeutix, Inc. | OCUL | $7.57 | -0.92% | 770 | 894 | $1,190 | $4.81 | 57.4% |
Enlivex Therapeutics Ltd. | ENLV | $1.10 | 2.8% | 30 | 217 | $24 | $3.30 | -66.7% |
Actuate Therapeutics Inc | ACTU | $8.81 | -2.33% | 15 | 54 | $172 | $8.61 | 2.3% |
Cardiol Therapeutics Inc. | CRDL | $1.33 | -8.14% | 295 | 364 | $109 | $0.88 | 51.4% |
Shattuck Labs, Inc. | STTK | $1.18 | -4.84% | 144 | 235 | $56 | $7.56 | -84.4% |